Androgen receptor and vitamin D receptor in human ovarian cancer: Growth stimulation and inhibition by ligands

International Journal of Cancer

Volumn 86, Issue 1, 2000, Pages 40-46

  Ahonen, Merja H ^a   Zhuang, Ya Hua ^a   Aine, Risto ^b   Ylikomi, Timo ^a,b   Tuohimaa, Pentti ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; CALCITRIOL; VITAMIN D RECEPTOR;

ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; GRANULOSA CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOLECULAR INTERACTION; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; THECA CELL; WESTERN BLOTTING;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BLOTTING, WESTERN; CALCITRIOL; CELL DIFFERENTIATION; CELL DIVISION; DIHYDROTESTOSTERONE; FEMALE; HUMANS; LIGANDS; MIDDLE AGED; OVARIAN NEOPLASMS; OVARY; RATS; RECEPTORS, ANDROGEN; RECEPTORS, CALCITRIOL; STIMULATION, CHEMICAL; TUMOR CELLS, CULTURED;

EID: 0034007512     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(20000401)86:1<40::AID-IJC6>3.0.CO;2-E     Document Type: Article

References (28)

1. ADASHI, E.Y., The climacteric ovary as a functional gonadotropin-driven androgen-producing gland. Fertility Sterility, 62, 20-27 (1994).
2. ARMSTRONG, D.T. and PAPKOFF, H., Stimulation of aromatization of exogenous and endogenous androgens in ovaries of hypophysectomized rats in vivo by follicle stimulating hormone. Endocrinology, 99, 1144-1151 (1976).
3. 3. Biochem. J., 316, 361-371 (1996).
4. DIETL, J. and MARZUSCH, K., Ovarian surface epithelium and human ovarian cancer. Gynecol. Obstet. Invest., 35, 129-135 (1993).
5. 3 receptors in T47D breast cancer cells. J. Steroid Biochem. mol. Biol., 45, 257-263 (1993).
6. EVANS, R.M., The steroid and thyroid hormone receptor superfamily. Science, 240, 889-895 (1988).
7. HALLORAN, B.P. and DELUCA, H.F., Effect of vitamin D deficiency on fertility and reproductive capacity in the female rat. J. Nutr., 110, 1573-1580 (1980).
8. HORIE, K., TAKAKURA, K., FUJIWARA, H., SUGIMANI, H., LIAO, S. and MORI, T., Immunohistochemical localization of androgen receptor in the human ovary throughout the menstrual cycle in relation to oestrogen and progesterone receptor expression. Hum. Reprod., 7, 184-190 (1992).
9. HURST, H.C., MASSON, N., JONES, N.C. and LEE, K.A.W., The cellular transcription factor CREB corresponds to activating transcription factor 47 (ATF-47) and forms complexes with a group of polypeptides related to ATF-43. Mol. cell. Biol., 10, 6192-6203 (1990).
10. 3 receptor in rat reproductive tissues. Histochem. Cell Biol., 105, 7-15 (1996).
11. KARLAN, B.Y., JONES, J.L., GREENWALD, M. and LAGASSE, L.D., Steroid hormone effects on the proliferation of human ovarian surface epithelium in vitro. Amer. J. Obstet. Gynecol., 173, 97-104 (1995).
12. 3 receptor (VDR) expression in human prostate. J. Steroid Biochem. mol Biol., 66, 121-127 (1998).
13. KUENG, W., SILBER, E. and EPPENBERGER, U., Quantification of cells cultured on 96-well plates. Anal. Biochem., 182, 16-19 (1989).
14. KÜHNEL, R., DE GRAAFF, J., RAO, B.R. and STOLK, J.G., Androgen receptor predominance in human ovarian carcinoma. J. Steroid Biochem., 26, 393-397 (1987).
15. LAEMMLI, U.K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.), 221, 680-685 (1970).
16. LEFKOWITZ, E.S. and GARLAND, C.F., Sunlight, vitamin D, and ovarian cancer mortality rates in US women. Int. J. Epidemiol., 23, 1133-1136 (1994).
17. LI, Y.C., PIRRO, A.E., AMLING, M., DELLING, G., BARON, R., BRONSON, R. and DEMAY, M.B., Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc. nat. Acad. Sci. (Wash.), 94, 9831-9835 (1997).
18. LOWRY, O.H., ROSEBROUGH, N.J., FARR, A.L. and RANDALL, R.J., Protein measurement with Folin phenol reagent. J. biol. Chem., 193, 265-275 (1951).
19. MAHLCK, C.G., BACKSTROM, T. and KJELLGREN, O., Androstenedione production by malignant epithelial ovarian tumors. Gynecol. Oncol., 25, 217-222 (1986).
20. 3 in gynecologic neoplasms. Gynecol. Oncol., 44, 131-136 (1992).
21. 3, retinoic acid and dexamethasone. Anticancer Drugs, 4, 201-208 (1993).
22. SLOTMAN, B.J., NAUTA, J.J.P. and RAO, B.R., Survival of patients with ovarian cancer - apart from stage and grade, tumor progesterone receptor content is a prognostic indicator. Cancer, 66, 740-744 (1990).
23. SLOTMAN, B.J. and RAO, B.R., Response to inhibition of androgen action of human ovarian cancer cells in vivo. Cancer Lett., 45, 213-220 (1989).
24. TÄHKÄ, K.M., ZHUANG, Y.-H., TÄHKÄ, S. and TUOHIMAA, P., Photoperiod-induced changes in androgen receptor expression in testes and accessory sex glands of the bank vole, Clethrionomys glareolus. Biol. Reprod., 56, 898-908 (1997).
25. TETSUKA, M., WHITELAW, P.F., BREMNER, W.J., MILLAR, M.R., SMYTH, C.D. and HILLIER, S.G., Developmental regulation of androgen receptor in rat ovary. J. Endocrinol., 145, 535-543 (1995).
26. THOMPSON, M.A. and ADELSON, M.D., Aging and development of ovarian epithelial carcinoma: the relevance of changes in ovarian stromal androgen production. Adv. exp. Med. Biol., 330, 155-165 (1993).
27. YOSHIZAWA, T. and 13 OTHERS, Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nature (Genet.), 16, 391-396 (1997).
28. 3 actions in LnCaP human prostate cancer cells are androgen-dependent. Endocrinology, 138, 3290-3298 (1997).